Main Industry
Health Care
Main Product/Service
1. iMET: An intramedullary transillumination device that utilizes optical technology to determine the position of distal screws. This solution significantly reduces X-ray exposure, shortens targeting time, and improves positioning accuracy.
2. iKypho: A surgical device featuring intelligent negative-pressure-guided bone cement technology paired with PVP or PKP. Without disrupting existing surgical workflows, it significantly reduces the risk of bone cement leakage and enhances filling uniformity, thereby addressing the unmet clinical needs of this minimally invasive surgery.
2. iKypho: A surgical device featuring intelligent negative-pressure-guided bone cement technology paired with PVP or PKP. Without disrupting existing surgical workflows, it significantly reduces the risk of bone cement leakage and enhances filling uniformity, thereby addressing the unmet clinical needs of this minimally invasive surgery.
The content above was translated by Ai
Founded Year
2022
Unified Business No.
90041191
Status
Active
Number of Employees
0
Total Paid-in
Capital
15,400,000 (NT$)
Location of Company
Taiwan
, New Taipei City
Website
Company names, registration status, legal representatives, founding years, paid-in capital, registered addresses, and other details are sourced from business registration records maintained by Taiwan’s Administration of Commerce, Ministry of Economic Affairs. Exit status includes Emerging Stock Board listings, M&A, and IPOs. Information on overseas expansion is self-reported by startups.
Note 1: FINDIT compiles company information from public and other sources for reference and does not serve as a point of contact for the companies listed.
Note 2: Some company profiles and product/service descriptions are translated using AI and provided for reference only. In case of discrepancies or ambiguity, the original text prevails.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
聯創生醫 is dedicated to addressing unmet needs in orthopedics and promoting patient health. Currently composed of two professors, three doctors, and four PhDs, we have three industry-academia collaboration channels; furthermore, we have applied for fifteen patents globally. One of our products has obtained FDA 510(k) clearance and QMS certification, while another product joined the FDA STeP program in September 2022 and is currently accelerating its path to US market launch.
The content above was translated by Ai
